Category: Business of health

1 7/20/2017

Journalists and consumers need to immunize themselves against hype about unproven vaccines

7/19/2017

Stem cell ads: Promise much, deliver little

4 5/16/2017

Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings

1 5/11/2017

Why we should all be wary when PR machines promote phase 2 studies

4 4/3/2017

‘Fake breakthrough, fake news:’ One physician-researcher’s takeaway on news coverage of MS drug Ocrevus

2 3/16/2017

Strip mall stem cells

7 2/23/2017

MD Anderson Cancer Center’s IBM Watson project fails, and so did the journalism related to it

2/20/2017

‘Are YOUR lips attractive?’ Clickbait science fuels clickbait journalism

13 1/31/2017

One key detail you’re unlikely to see in news stories about mammography screening guidelines

1 1/27/2017

Tribune exposé on drug interactions reprises 20-year-old U.S. News report–highlights empty promises of pharmacy reform